EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access

Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma: A Meta-Analysis of Large Randomized Controlled Trials

Huanwen Chen, Matthew K McIntyre, Peter Kan iD, Dheeraj Gandhi, Marco Colasurdo iD

American Journal of Neuroradiology · 2025-10 · 46 (10) · 2069-2074

DOI: 10.3174/ajnr.a8781 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift American Journal of Neuroradiology, online erschienen am 09.04.2025. Verfasst von Huanwen Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Neurology (H.C.), MedStar Georgetown University Hospital, Washington, DC. Hauptthemen laut MEDLINE: Embolization, Therapeutic, Meningeal Arteries, Hematoma, Subdural. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Middle meningeal artery embolization (MMAE) has emerged as a novel treatment for non-acute subdural hematoma (SDH), particularly for reducing the risk of SDH recurrence. Recently, 5 randomized controlled trials (RCTs) of MMAE as an adjunct to conventional management (surgical or observant) have concluded their investigation and reported their outcomes. PURPOSE: Our goal was to synthesize trial results to provide more definitive guidance on the role of MMAE in the management of non-acute SDH. DATA SOURCES: The MEDLINE database from inception up to November 23, 2024 was used. English-language clinical articles reporting large randomized controlled trials (n = 100 or more) investigating the efficacy and safety of MMAE for patients with non-acute subdural hematoma were identified. STUDY SELECTION: Five trials were identified-EMBOLISE, STEM, MAGIC-MT, EMPROTECT, and MEMBRANE. DATA ANALYSIS: The primary efficacy end point was SDH treatment failure (broadly defined as SDH recurrence or requirement of surgical rescue) within 3 to 6 months. Safety end points include death and stroke. DATA SYNTHESIS: There was significant heterogeneity in terms of patient populations as well as reported outcomes. Overall, MMAE was associated with significantly lower odds of SDH treatment failure (OR 0.51 [95% CI 0.39-0.67], P < .001), with minimal inter study heterogeneity. Compared with conventional management, MMAE was not significantly associated with different odds of death (OR 1.03 [95% CI 0.36-2.99], P = .95) or stroke (OR 1.10 [95% CI 0.36-3.39], P = .86). LIMITATIONS: Our meta-analysis is limited by selection bias and high heterogeneity in study design and reported outcomes. CONCLUSIONS: This study provides high-level evidence that, for patients with non-acute SDH, MMAE is a safe and effective adjunct to conventional management for preventing treatment failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embolization, TherapeuticMeningeal ArteriesHematoma, SubduralHumansRandomized Controlled Trials as TopicTreatment Outcome

Autor:innen und Institutionen

  • From the Department of Neurology (H.C.), MedStar Georgetown University Hospital, Washington, DC.
  • Department of Neurosurgery (M.K.K.), Oregon Health & Science University, Portland, Oregon.
  • Department of Neurosurgery (P.K.), University of Texas Medical Branch, Galveston, Texas.
  • Departments of Radiology, Neurology, and Neurosurgery (D.G.), University of Maryland Medical Center, Baltimore, Maryland.
  • Department of Interventional Radiology (M.C.), Oregon Health & Science University, Portland, Oregon mcolasurdo@gmail.com.

ORCID-Profile: Peter Kan, Marco Colasurdo

Zitieren

APA

Chen, H., McIntyre, M. K., Kan, P., Gandhi, D., & Colasurdo, M. (2025). Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma: A Meta-Analysis of Large Randomized Controlled Trials. American Journal of Neuroradiology, 46(10), 2069-2074. https://doi.org/10.3174/ajnr.a8781

Vancouver

Chen H, McIntyre MK, Kan P, Gandhi D, Colasurdo M. Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma: A Meta-Analysis of Large Randomized Controlled Trials. American Journal of Neuroradiology. 2025;46(10):2069-2074. doi:10.3174/ajnr.a8781

BibTeX
@article{Chen2025,
  author = {Chen, Huanwen and McIntyre, Matthew K and Kan, Peter and Gandhi, Dheeraj and Colasurdo, Marco},
  title = {Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma: A Meta-Analysis of Large Randomized Controlled Trials},
  journal = {American Journal of Neuroradiology},
  year = {2025},
  volume = {46},
  number = {10},
  pages = {2069--2074},
  doi = {10.3174/ajnr.a8781}
}
Kostenlos starten →